Indication: Pulmonary Arterial Hypertension
Retrospective Evaluation of Pulmonary Arterial Hypertension (PAH) Patients: Real-World Experience from the Trio Health Network
Sub-indication: Pulmonary Arterial Hypertension (PAH)
Study Type: Registry
Principal Investigator: John McConnell, M.D.Norton Pulmonary Specialists
Sponsor: Sponsor: Actelion Pharmaceuticals US, Inc